{
  "$type": "site.standard.document",
  "bskyPostRef": {
    "cid": "bafyreienlro6hwltudtojp6mhbxv77qdsna3ku24pebkxydvnqlditleiy",
    "uri": "at://did:plc:pmmp7irwts7faw56jdxk3idc/app.bsky.feed.post/3mhwexs52vjn2"
  },
  "coverImage": {
    "$type": "blob",
    "ref": {
      "$link": "bafkreibexoyjrdrypjig3c4tl22gyshel56y7lovwupkgb67wojfgnjoca"
    },
    "mimeType": "image/jpeg",
    "size": 387601
  },
  "path": "/news/2026-03-elinzanetant-severity-frequency-hot-night.html",
  "publishedAt": "2026-03-25T19:10:07.000Z",
  "site": "https://medicalxpress.com",
  "textContent": "Results from the OASIS 4 clinical trial show that a new drug, elinzanetant, relieved hot flashes and night sweats that can occur because of the menopause or because of hormone treatment for breast cancer. Now, a new analysis of data from the trial shows that it also gives sustained relief regardless of the type of hormone treatment cancer patients receive.",
  "title": "Elinzanetant reduces severity and frequency of hot flashes and night sweats in breast cancer patients: Clinical trial"
}